 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: COPAXONE, GLATOPA (glatiramer acetate) |
|
***************************************************** |
|
#Post#: 4605-------------------------------------------------- |
|
Teva facing �463M fine over Copaxone misconduct claims |
|
By: agate Date: October 31, 2024, 8:25 pm |
|
--------------------------------------------------------- |
|
Now that there is a plethora of MS drugs available, those who |
|
enjoy entertaining spectacles can watch while the drug companies |
|
duke it out for the privilege of getting our insurance company |
|
dollars (or somebody's dollars/euros)--and often it's a lifetime |
|
commitment to an MS drug. Here is yet another instance where a |
|
drug company has gone too far in its attempts at cornering the |
|
market. |
|
From FiercePharma (October 31, 2024)--"Teva Slapped with �463M |
|
Fine over Copaxone Misconduct Claims in EU": |
|
https://www.fiercepharma.com/pharma/teva-slapped-eu463m-fine-over-accusations-i… |
|
***************************************************** |
